Actitropil, tablets 100 mg 30 pcs
€27.14 €22.62
Out of stock
(E-mail when Stock is available)
Pharmacotherapeutic group: nootropic agent.
ATX code: N06BX
Pharmacological properties
Pharmacodynamics
A nootropic medicine with a pronounced anti-amnesic effect, direct activation of integrative activity of the brain, promotes memory consolidation, improves concentration and mental performance, facilitates learning, increases the speed of information transfer between the cerebral hemispheres, increases resistance of brain tissue to hypoxia and toxic effects, has anticonvulsant and anxiolytic activity, regulates the processes of activation and inhibition of the central nervous system, improves the blood circulation in the brain and brain tissue.
It has a positive effect on metabolic processes and blood circulation in the brain, stimulates redox processes, increases the body’s energy potential by utilizing glucose, improves regional blood flow in ischemic brain areas. Increases the content of noradrenaline, dopamine and serotonin in the brain, does not affect the level of GABA, does not bind to either GABAA or GABAB receptors, has no noticeable effect on spontaneous bioelectrical activity of the brain.
It has no effect on respiration and cardiovascular system, shows a subtle diuretic effect, has anorexigenic activity when used as a course.
The stimulant action is manifested by its ability to produce a moderately pronounced effect on motor reactions, increased physical performance, a pronounced antagonism to the cataleptic action of neuroleptics, and a decrease in the severity of the sleeping effect of ethanol and hexenal.
The psychostimulant effect is predominant in the ideational sphere.
Moderate psychostimulant effect of the drug is combined with anxiolytic activity, improves mood, has some analgesic effect, increasing the threshold of pain sensitivity.
The adaptogenic effect is shown in increasing the body’s resistance to stress under conditions of excessive mental and physical exertion, fatigue, hypokinesia and immobilization, at low temperatures.
An improvement of vision was noted during taking, which is manifested by an increase in the acuity, brightness and visual fields.
It improves blood supply to the lower extremities.
Stimulates the production of antibodies in response to antigen introduction, which indicates its immunostimulatory properties, but at the same time it does not promote immediate-type hypersensitivity and does not change the allergic inflammatory skin reaction caused by the introduction of a foreign protein.
The drug does not develop drug dependence, tolerance or withdrawal syndrome when used with a course of treatment.
The action starts with a single dose, which is important when using the drug in extreme conditions.
It does not have teratogenic, mutagenic, carcinogenic and embryotoxic properties. Toxicity is low, the lethal dose in an acute experiment is 800 mg/kg.
Pharmacokinetics
absorption
It is rapidly absorbed, penetrates various organs and tissues, and easily passes through the blood-brain barrier.
Distribution
absolute bioavailability when taken orally is 100%. Maximal concentration in blood (Тmax) is reached after 1 hour, the half-life (Т1/2) – 3 – 5 h.
Metabolism
Not metabolized in the body.
Evolution
It is excreted unchanged: about 40% – with urine and 60% – with bile and sweat.
Indications
– CNS diseases of different genesis, especially associated with vascular diseases and disorders of metabolic processes in the brain, intoxication (in particular, in post-traumatic states and phenomena of chronic cerebrovascular failure), accompanied by deterioration of intellectual and mental functions, decreased motor activity;
– Neurotic conditions, manifested by lethargy, increased exhaustion, decreased psychomotor activity, impaired attention, impaired memory;
– Learning disorders;
– Obesity (of alimentary and constitutional genesis);
– Prevention of hypoxia, increasing resistance to stress, correction of the functional state of the body under extreme conditions of professional activity in order to prevent the development of fatigue and to improve mental and physical performance;
– Chronic alcoholism (in order to reduce symptoms of asthenia, intellectual and mental disorders).
Composition
Per 1 tablet:
The active substance:
Fonturacetam – 118.0 mg (in terms of 100% substance) – 100.00 mg
Excipients:
Cellulose microcrystalline 101 – 18.0 mg,
Povidone K-17 (polyvinylpyrrolidone low molecular weight K-17) – 40.0 mg,
Hyprolose (hydroxypropyl cellulose) – 20.0 mg,
Sodium bicarbonate-20.0 mg,
Stearic acid – 2.0 mg.
How to take, the dosage
Ingestion.
Take immediately after a meal. The dose and duration of treatment should be determined by the doctor. Doses vary according to the characteristics of the patient’s condition. The average single dose is 150 mg (100 to 250 mg); the average daily dose is 250 mg (200 to 300 mg). The maximum tolerated dose is 750 mg/day. It is recommended that a daily dose of up to 100 mg should be taken once in the morning, and over 100 mg should be divided into 2 doses. The duration of treatment may vary from 2 weeks to 3 months, on average 30 days. If necessary, the course can be repeated after 1 month.
To improve performance, 100 to 200 mg once in the morning hours, for 2 weeks (for athletes, 3 days).
The recommended duration of treatment for patients with alimentary-constitutional obesity is 30 to 60 days at a dose of 100 to 200 mg once a day (in the morning hours). It is not recommended to take the drug later than 3 p.m.
Interaction
Fonturacetam may increase the effect of CNS stimulating drugs, antidepressants and nootropic drugs.
The drug shows pronounced antagonism to the cataleptic action of neuroleptics, and also reduces the severity of the sleeping effects of ethanol and hexobarbital.
Special Instructions
With caution
.
Patients with severe organic lesions of the liver and kidneys, severe arterial hypertension, with significant atherosclerosis, who have previously had panic attacks, acute psychotic states with psychomotor agitation – due to the possibility of exacerbation of anxiety, panic, hallucinations and delirium, as well as patients who are prone to allergic reactions to nootropics of pyrrolidone group.
Special indications
In excessive psychoemotional exhaustion due to chronic stress and fatigue, chronic insomnia, a single drug administration in the first day may cause a sharp need for sleep. It should be recommended that outpatients start a course of the drug on non-working days to these patients.
Influence on driving, operating machinery
Caution should be exercised when driving vehicles and machinery, especially in the first days of administration, given the possible occurrence of drowsiness (see
Contraindications
– Hypersensitivity to the active ingredient and/or any excipient of the drug;
– Pregnancy;
– Breast-feeding period;
– Childhood under 18 years (safety and effectiveness of the drug have not been established)
Overdose
There have been no cases of overdose.
Treatment: symptomatic therapy.
Pregnancy use
Do not prescribe during pregnancy and while breastfeeding due to lack of clinical trial data.
Weight | 0.020 kg |
---|---|
Shelf life | 2 years. Do not use after the expiration date stated on the package. |
Conditions of storage | Store in the original package at the temperature not more than 25 °С. Keep out of reach of children. |
Manufacturer | Pharmstandard-Leksredstva, Russia |
Medication form | pills |
Brand | Pharmstandard-Leksredstva |
Related products
Buy Actitropil, tablets 100 mg 30 pcs with delivery to USA, UK, Europe and over 120 other countries.